Skip to main content

Ian Davis, MD, PhD, is a UNC Lineberger Comprehensive Cancer Center member involved with the Cancer Genetics, Pediatric Hematology-Oncology, and Cancer Epigenetics Training programs.

MD, PhD
G. Denman Hammond Professor of Childhood Cancer
Co-Leader, UNC Lineberger Cancer Genetics Research Program
Associate Chief, Division of Pediatric Hematology-Oncology
Associate Director, Cancer Epigenetics Training Program
UNC-Chapel Hill
Cancer Genetics

Area of Interest

I am interested in the application of integrated genome-wide approaches to identify the epigenetic and chromatin biology consequences of genetic alterations in human cancers. Primary foci of the lab include Ewing sarcoma in which we explore the mechanism through which the necessary chromosomal translocation-derived fusion oncoprotein EWSR1-FLI1 regulates chromatin states and target genes. We also are evaluating the effect of mutations in the histone methyltransferase SETD2 and the chromatin remodeling complex member PBRM1 in clear cell renal cell carcinoma. Because of our expertise in epigenomics, we also collaborate with labs across the campus studying other cancers and developmental disorders.

Find publications on PubMed

Awards and Honors

  • Dick Vitale Pediatric Cancer Research Fund, The V Foundation, 2023
  • G. Denman Hammond Professorship for Childhood Cancer
  • Martin D. Abeloff V Scholar Award
  • Rita Allen Foundation Scholar

News and Stories


View all related posts

Headshot of Ian Davis.